Peter A Nigrovic Selected Research

Peter A Nigrovic Research Topics

Disease

33	Arthritis (Polyarthritis) 02/2024 - 03/2006
26	Inflammation (Inflammations) 12/2023 - 01/2005
22	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2024 - 01/2008
12	Rheumatoid Arthritis 10/2023 - 05/2008
7	Macrophage Activation Syndrome 11/2023 - 01/2018
6	Experimental Arthritis 11/2016 - 01/2009
3	Exanthema (Rash) 10/2023 - 01/2008
3	Uveitis 01/2022 - 01/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 09/2012
3	Autoimmune Diseases (Autoimmune Disease) 10/2019 - 06/2013
3	Rheumatic Diseases (Rheumatism) 01/2018 - 03/2012
3	Synovitis 12/2016 - 04/2006
2	Eosinophilia 10/2023 - 10/2023
2	Lung Diseases (Lung Disease) 10/2023 - 01/2022
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 08/2023 - 06/2006
2	Vasculitis (Vasculitides) 01/2023 - 01/2020
2	Pure Red-Cell Aplasia 01/2023 - 01/2020
2	Ankylosing Spondylitis 08/2022 - 04/2022
2	Necrosis 01/2022 - 10/2016
2	Lyme Disease (Disease, Lyme) 10/2021 - 05/2014
2	Peritonitis 12/2019 - 07/2014
2	Fever (Fevers) 02/2019 - 02/2011
2	Sacroiliitis 01/2019 - 01/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018 - 06/2013
2	Disease Progression 11/2016 - 02/2011
2	Infections 07/2014 - 05/2013
2	Tuberculosis (Tuberculoses) 10/2013 - 10/2013
1	Adult-Onset Still's Disease 01/2024
1	Down Syndrome (Down's Syndrome) 10/2023
1	Anaphylaxis (Anaphylactic Shock) 10/2023
1	Drug Hypersensitivity (Drug Allergy) 10/2023
1	Aneurysm (Aneurysms) 08/2023
1	Simian Acquired Immunodeficiency Syndrome 01/2023
1	Burns 01/2023
1	Genetic Risk Score 04/2022
1	Pain (Aches) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Drug Hypersensitivity Syndrome 01/2022
1	Gout 01/2022
1	Hyperuricemia 01/2022

Drug/Important Bio-Agent (IBA)

15	AutoantibodiesIBA 01/2022 - 03/2006
11	Interleukin-1 (Interleukin 1)IBA 10/2023 - 02/2007
8	CytokinesIBA 10/2023 - 01/2005
8	AntigensIBA 01/2023 - 03/2006
7	Immunoglobulin G (IgG)IBA 10/2021 - 11/2010
6	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 03/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2012
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2018
4	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 10/2016
4	AntibodiesIBA 01/2020 - 03/2006
4	Complement System Proteins (Complement)IBA 01/2019 - 06/2006
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2019 - 11/2010
4	AutoantigensIBA 12/2016 - 06/2013
3	Interferon-gamma (Interferon, gamma)IBA 12/2023 - 01/2022
3	Interferon Type IIBA 11/2023 - 10/2016
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2016
3	Leukotriene B4IBA 01/2023 - 04/2006
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 08/2022 - 01/2008
3	Adalimumab (Humira)FDA Link 01/2022 - 01/2019
3	GlucocorticoidsIBA 01/2019 - 01/2018
3	Polysaccharides (Glycans)IBA 12/2017 - 03/2012
3	CollagenIBA 01/2016 - 06/2007
2	TNF Receptor-Associated Factor 1IBA 02/2024 - 11/2023
2	Interleukin-17 (Interleukin 17)IBA 08/2023 - 11/2019
2	chlorotriphenylsilane (CTPS)IBA 12/2022 - 04/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2022 - 05/2017
2	EnzymesIBA 10/2021 - 01/2020
2	pristane (pristan)IBA 10/2020 - 01/2019
2	InterferonsIBA 01/2020 - 09/2012
2	Ferritins (Ferritin)IBA 02/2019 - 02/2011
2	Infliximab (Remicade)FDA Link 01/2019 - 01/2019
2	Monoclonal AntibodiesIBA 01/2019 - 01/2019
2	Glycoproteins (Glycoprotein)IBA 05/2017 - 01/2010
2	Chemokine ReceptorsIBA 01/2016 - 01/2009
2	Interleukin-33IBA 07/2014 - 01/2012
2	Antinuclear AntibodiesIBA 05/2014 - 09/2012
2	Peptides (Polypeptides)IBA 06/2013 - 03/2012
2	Fc Receptors (Fc Receptor)IBA 09/2012 - 03/2010
2	ProstaglandinsIBA 09/2012 - 05/2008
2	Anaphylatoxin C5a ReceptorIBA 11/2010 - 03/2010
2	Tryptases (Tryptase)IBA 07/2010 - 01/2009
2	LeukotrienesIBA 03/2010 - 04/2006
1	ChromatinIBA 12/2023
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023
1	LuciferasesIBA 11/2023
1	Interleukin-6 InhibitorsIBA 10/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	ProteomeIBA 01/2022
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022
1	methylglyoxal bis(butylamidinohydrazone)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022

Therapy/Procedure

15	Therapeutics 01/2024 - 02/2011
3	Biological Therapy 10/2023 - 01/2018
1	Lasers (Laser) 01/2023